Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - Pliant Therapeutics (NASDAQ:PLRX)

PLIANT THERAPEUTICS, INC. (PLRX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 plrx-2026811xexx991.htm EX-99.1 Document Exhibit 99.1 Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results FORTIFY, a Phase 1b indication expansion trial of PLN-101095, experiencing strong enrollment Appointed seasoned oncology

According to NewsWire, NSW Premier Chris Minns and federal PM Anthony Albanese are set to sign a bailout agreement with Rio Tinto for the Tomago aluminium smelter in Hunter Valley. Rio Tinto, which has a majority stake, warned it may shut Tomago if affordable long term power is not secured by 2028. The plan may involve Snowy Hydro 2.0 underwriting renewable power costing over $300m per year for 10 years.

Phillips 66, Kinder Morgan and HF Sinclair said they made a final investment decision to proceed with the $5 billion Western Gateway Pipeline, aiming for completion in 2029 subject to permits. The 1,300-mile system would move refined fuels into the West with 230,000 bpd capacity and potential Southern California gasoline price relief. Ownership: Phillips 66 49.9%, Kinder Morgan 35.1%, HF Sinclair 15%.

Glenmark Pharmaceuticals’ U.S. unit said, in an exchange filing, it reached a settlement with Humana to resolve antitrust litigation tied to consolidated generic-drug price-fixing claims in the Eastern District of Pennsylvania. The settlement totals $15.28 million plus interest, paid in two installments. Glenmark denied the allegations and said the amount was already booked in its financial statements.

Boeing said the US Air Force awarded it a $75 million undefinitized contract action to start building the GBU-75 long-range guided bomb, combining a JDAM warhead with a wing kit and turbojet engine to reach over 300 nautical miles. Boeing invested nearly $100 million. The Navy plans initial deliveries after April 2026 tests.

An internal US Defense Department memo reportedly directs subordinates to buy up to $243.9 million in services from Palantir through March 31, 2027, without competitive bidding, and to identify additional funding for April 1, 2027 to Dec. 31, 2028. The memo cites Palantir support for defense industrial base efficiency and munitions/vehicle delays. Palantir is a public company.